Articles By Marcus Johnson

  1. GSK's Darapladib Doesn't Meet Expectations 4/14/2014

    Pharmaceutical giant GlaxoSmithKline announced that its late-stage study of darapladib, a heart disease drug developed by the company, did not meet expectations.

  2. Biogen Idec's Eloctate Drug Sees Late Trial Success 4/14/2014

    Biogen Idec along with partner Swedish Orphan Biovitrum announced that their experimental blood disorder drug, Eloctate, was effective in treating children with hemophilia in a late-stage trial.

  3. Roche Purchases Rights To Oryzon Genomics' Experimental Cancer Drug 4/14/2014

    Pharmaceutical giant Roche has purchased the rights to Oryzon Genomics' experimental cancer drug.

  4. Pfizer Experimental Breast Cancer Drug Shows Potential 4/14/2014

    The experimental palbociclib drug developed by pharmaceutical giant Pfizer has shown the potential to treat advanced breast cancer in clinical trials.

  5. European Parliament Votes In Favor Of Transparent Clinical Trials 4/10/2014

    The European Parliament voted in favor of new legislation that would change the way clinical trials are run in the European Union.

  6. Zogenix Suing State Of Massachusetts For Painkiller Ban 4/9/2014

    Zogenix, which manufacturers the painkiller Zohydro ER, is filing a complaint in the U.S. District Court against the state of Massachusetts for banning its opioid medication, Zohydro.

  7. FDA Approves Expanded Use Of Kalbitor For Angioedema Patients 12 & Older 4/9/2014

    Dyax has announced that the U.S. Food and Drug Administration (FDA) approved an extension of the indication for the drug Kalbitor (ecallantide).

  8. Agios Experimental Leukemia Drug Sees Success 4/9/2014

    Biotech firm Agios held a press conference detailing the success of their experimental leukemia drug, AG-221.

  9. Cancer Drugs Intended For Adults Help Children With Brain Tumor 3/28/2014

    St. Jude's Children's Research Hospital has tested two drugs that are currently used on adults with lung, pancreatic, and breast cancers.

  10. New Cancer Drug Developed In Taiwan Heading For US Clinical Trials 3/27/2014

    Taiwan's newly developed anti-cancer drug has been approved by the FDA for trials in the United States.